Workflow
中国三江化工(02198) - 2023 - 中期财报
CHINA SANJIANGCHINA SANJIANG(HK:02198)2023-09-15 08:54

Financial Performance - For the six months ended June 30, 2023, the company recorded a slight gross loss margin of 2.4%, a decrease of approximately 4.4% compared to the previous year[7]. - Revenue decreased by approximately 5.6% due to lower average selling prices and production capacity of key products including ethylene oxide, ethylene glycol, and polypropylene[8]. - Shareholders' net profit for the period was approximately RMB 26.1 million, with basic earnings per share of RMB 0.0222, influenced by one-time items including a RMB 115 million loan assumption from a joint venture partner[8]. - The overall gross margin decline was primarily due to a 12.0% decrease in methanol pricing, which constitutes about 70% of the company's total raw material procurement[10]. - The company reported a profit of RMB 7,367,000 for the six months ended June 30, 2023, compared to a loss of RMB 75,258,000 in the same period of 2022, marking a significant turnaround[67]. - Total comprehensive income for the period was RMB 7,367,000, a recovery from a comprehensive loss of RMB 75,258,000 in the previous year[67]. - The profit attributable to equity holders of the parent company was RMB 26,121,000, compared to a loss of RMB 62,689,000 in the prior year[67]. - The net loss before tax was RMB 44,457 thousand, an improvement from a loss of RMB 63,746 thousand in the previous year[65]. Revenue and Sales - Total revenue for the first half of 2023 was RMB 4,591,142,000, a decrease of 5.6% compared to RMB 4,864,325,000 in the same period of 2022[50]. - The revenue from the ethylene oxide business line was approximately RMB 745.8 million, a decrease of about 45.0% compared to the same period in 2022, primarily due to a production reduction of approximately 35.3%[53]. - The glycol business line generated revenue of approximately RMB 457.5 million, down about 9.8% year-on-year, mainly due to a 19.0% decline in average selling prices during the review period[54]. - The polypropylene business line's revenue decreased by approximately 18.5% compared to the same period in 2022, attributed to a 14.4% reduction in average selling prices[55]. - The company has seen a 95% increase in revenue from surfactants in the first half of 2023 compared to the same period in 2022[10]. Production and Capacity - The company anticipates improvement in gross margin in the second half of 2023, supported by the new production facilities that will double its market share in East China[11]. - The new production facilities, with an annual capacity of 1,000,000 tons, are expected to rebalance raw material composition from 20%-10%-70% (ethylene, propylene, methanol) to 70%-30% (naphtha, ethane, propane) starting Q3 2023[7]. - The sales volume of ethylene oxide decreased by 35.3% to 128,923 tons from 199,279 tons in the first half of 2022[50]. Cash Flow and Financial Position - The net cash flow from operating activities was negative at RMB 337,562,000, an improvement from negative RMB 604,775,000 in the same period last year[70]. - The net cash flow from investing activities was negative RMB 811,957,000, down from negative RMB 1,603,676,000 in the previous year[70]. - The net cash flow from financing activities was RMB 1,451,310,000, compared to RMB 1,955,920,000 in the same period of 2022[70]. - The company ended the period with cash and cash equivalents of RMB 522,490,000, an increase from RMB 342,806,000 at the end of the previous year[70]. - The company has a net current liability of approximately RMB 6,970,170,000 as of June 30, 2023, indicating a need for sufficient operating cash flow and financing capabilities[77]. Debt and Liabilities - The group's debt-to-asset ratio as of June 30, 2023, was 54.67%, compared to 57.50% as of December 31, 2022, with a guideline not exceeding 66.7%[30]. - The total current liabilities increased from RMB 10,608,821 thousand to RMB 13,124,255 thousand, indicating a rise in financial obligations[60]. - The group’s total liabilities increased significantly, with bank loans and other borrowings rising to RMB 3,067,104 thousand as of June 30, 2023, compared to RMB 2,833,614 thousand at the end of 2022, an increase of about 8.2%[115]. - The company has a total of RMB 8,167,458,000 in bank loans due within one year as of June 30, 2023, compared to RMB 7,228,416,000 as of December 31, 2022, indicating an increase of approximately 13.0%[123]. Corporate Governance and Compliance - The company has adopted the corporate governance code as per the Hong Kong Stock Exchange rules and has complied with all provisions during the reporting period[46]. - The company confirmed compliance with the standard code for securities transactions by directors and senior management during the reporting period[47]. - The group did not declare an interim dividend for the periods ended June 30, 2023, and 2022, reflecting a conservative approach amid financial recovery efforts[107]. Shareholder Information - The company’s major shareholders include Han Jianhong and Guan Siyu, who collectively hold approximately 45.15% of the issued share capital[138]. - As of June 30, 2023, Sure Capital Holdings Limited holds 516,496,000 shares, representing approximately 43.40% of the issued share capital[144]. - Sure Capital is wholly owned by Yihao Development Limited, which is held by Yihao Trust, with Vistra Trust (Singapore) Pte. Ltd. as the trustee[145]. - The beneficial owners of Yihao Trust include Mr. Guan and Ms. Han, along with their children[145]. Acquisition and Investments - The acquisition of a 50% stake in Sanjiang Lotte Chemical Co., Ltd. was completed on June 20, 2023, resulting in the company gaining full control with a total equity interest of 100%[130]. - The fair value of identifiable assets and liabilities of Sanjiang Lotte at the acquisition date was assessed at RMB 167,138,000, with a bargain purchase gain of RMB 83,569,000 recorded[132]. - The cash flow analysis post-acquisition indicated a net cash inflow of RMB 116,824,000 from investment activities, reflecting the financial impact of the acquisition[134].